Risk factors for hepatocellular carcinoma: A case-control study in Belgrade (Serbia)

Tumori

Volumn 96, Issue 6, 2010, Pages 911-917

  Kanazir, Milena ^a   Boricic, Ivan ^b   Delic, Dragan ^c   Tepavcevic, Darija Kisic ^b   Knezevic, Aleksandra ^b   Jovanovic, Tanja ^b   Pekmezovic, Tatjana ^b  

^a Institute of Public Health of Serbia   (Serbia)

^b Dedinje Cardiovascular Institute   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Case control study; Hepatocellular carcinoma; Risk factors

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SERBIA;

EID: 79551501347     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/548.6508     Document Type: Article

References (31)

1. Lau WY, Lai ECH: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int, 7: 237-257, 2008.
2. Parkin DM: Cancer incidence in five continents. IARC scientific publication. Vol VIII (No. 155). IARC Press, Lyon, 2002.
3. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK: Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol, 22: 1104-1111, 2007.
4. Braga C, La Vecchia C, Negri E, Franceschi S: Attributable risk for hepatocellular carcinoma in northern Italy. Eur J Cancer, 33: 629-634, 1997.
5. Montella M, Polesel J, La Vecchia C, Dal Maso L, Crispo A, Crovatto M, Casarin P, Izzo F, Tommasi LG, Talamini R, Franceschi S: Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer, 120: 1555-1559, 2007.
6. Porru S, Placidi D, Carta A, Gelatti U, Ribero ML, Tagger A, Boffetta P, Donato F: Primary liver cancer and occupation in men: a case-control study in a high-incidence area in northern Italy. Int J Cancer, 94: 878-883, 2001.
7. Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Takahashi I, Chayama K: Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev, 17: 846-854, 2008.
8. Talamani R, Polesel J, Montella M, Dal Maso L, Crispo A, Tommasi LG, Izzo F, Crovatto M, La Vecchia C, Franceschi S: Food groups and risk of hepatocellular carcinoma: a multicenter case-control study in Italy. Int J Cancer, 119: 2916-2921, 2006.
9. Miettinen OS: Simple interval estimations of risk ratio. Am J Epidemiol, 100: 515-516, 1974.
10. McNeil D: Epidemiological research methods. John Wiley and Sons, New York, 1996.
11. Bosch FX, Ribes J, Cleries R, Diaz M: Epidemiology of hepatocellular carcinoma. Clin Liver Dis, 9: 191-211, 2005.
12. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132: 2557-2576, 2007.
13. Ikeda K, Saitoh S, Arase Y, Chayama K, Suzuki Y, Kobayashi M, Tsubota A, Nakamura I, Murashima N, Kumada H, Kawanishi M: Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology, 29: 1124-1130, 1999.
14. Brunp S, Battezzati PM, Bellati G, Manzin A, Maggioni M, Crosignani A, Borzio M, Solforosi L, Morabito A, Ideo G, Podda M: Long-term beneficial effects in sustained responders to interferon-alpha therapy for chronic hepatitis C. J Hepatol, 34: 748-755, 2001.
15. Yoshizawa H: Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology, 62 (Suppl 1): 8-17, 2002.
16. Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, Decarli A, Trevisi P, Ribero ML, Martelli C, Porru S, Nardi G: Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol, 155: 323-331, 2002.
17. Donato F, Bofetta P, Puoti M: A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer, 75: 347-354, 1998.
18. Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, Hainaut P, Hall AJ, Whittle H, Montesano R: The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in west Africa. Hepatology, 39: 211-219, 2004.
19. Kuper H, Hsieh C, Stuver SO, Mucci LA, Tzonou A, Zavitsanos X, Lagiou P, Trichopoulos D: Birth order, as a proxy for age at infection, in the etiology of hepatocellular carcinoma. Epidemiology, 11: 680-683, 2000.
20. Hsieh C, Tzonou A, Zavitsanos X, Kaklamani E, Lan SJ, Trichopoulos D: Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study. Am J Epidemiol, 136: 1115-1121, 1992.
21. El-Serag HB, Hampel H, Javadi F: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol, 4: 369-380, 2006.
22. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology, 126: 460-468, 2004.
23. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO: Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst, 92: 1096-1099, 2000.
24. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, Hsu ST: A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer, 62: 2051-2055, 1988.
25. Veldt BJ, Chen W, Teathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL: Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology, 47: 1856-1862, 2008.
26. Mucci LA, Kuper HE, Tamimi R, Lagiou P, Spanos E, Trichopoulos D: Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. Br J Ostet Gynecol, 108: 291-294, 2001.
27. Yu MW, Chang H-C, Chang S-C, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ: Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis Band C-related risk. Hepatology, 38: 1393-1400, 2003.
28. La Vecchia C, Negri E, Decarli A, D'Avanzo B, Franceschi S: Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer, 42: 872-876, 1988.
29. Fukuda K, Shibata A, Hirohata I, Tanikawa K, Yamaguchi G, Ishii M: A hospital-based case-control study on hepatocellular carcinoma in Fukuoka and Saga Prefectures, northern Kyushu, Japan. Jpn J Cancer Res, 84: 708-714, 1993.
30. Yu MW, Chen CJ: Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res, 53: 790-794, 1993.
31. Yu SZ, Huang XE, Koide T, Cheng G, Chen GC, Harada K, Ueno Y, Sueoka E, Oda H, Tashiro F, Mizokami M, Ohno T, Xiang J, Tokudome S: Hepatitis B and C viruses' infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China. Jpn J Cancer Res, 93: 1287-1292, 2002.